ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,668, issued on Aug. 18, was assigned to Pfizer Inc. (New York).
"Stable aqueous anti-TFPI antibody formulation" was invented by Thomas Joseph Crowley (Wilmington, Mass.), Robert Lee Dufield (Overland Park, Kan.) and Jennifer Juneau (Sterling, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-Tissue Factor Pathway Inhibitor (TFPI) antibody."
The patent was filed on No...